US$ 21.48
dpp-4 inhibitors vs. glp-1 agonist Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology Cardiovascular effects of the DPP-4
Description
The company has also launched biscuits for diabetic patients with a lower glycemic index, he said

December 2022
35 SGLT-1 is primarily responsible for glucose absorption in the gastrointestinal tract and only accounts for approximately 10% of glucose reabsorption in the kidney

It means we do not have the quality of evidence needed to make confident claims about efficacy
After reviewing all clinical data for the medicine and consulting with regulators, Pfizer decided to halt research on it